HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Kezar Life Sciences (NASDAQ:KZR) from Buy to Neutral.
HC Wainwright & Co. Downgrades Kezar Life Sciences to Neutral
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.